Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006501 220011435 null null null null 2013-05-15 Nilotinib N N 220030439 NILOTINIB
220006502 220002505 null 58.3 Disease modification (D) 2014-05-30 2014-05-31 Nilotinib N N 220030443 NILOTINIB
220006503 220002505 null 74.5 Curative (C) 2013-12-10 2013-12-10 AML 19 TRIAL 1 N 220030443 AML19 TRIAL
220006504 220002505 1.57 116.6 Curative (C) 2014-10-24 2014-10-25 AML 19 TRIAL Y N 220030443 AML19 TRIAL
220006506 220011437 1.66 107.4 Curative (C) 2015-09-03 2015-10-24 AML 19 TRIAL Y N 220030451 AML19 TRIAL
220006507 220002507 null 127 null 2016-08-10 2016-08-10 AML 19 TRIAL 1 N 220030452 AML19 TRIAL
220006508 220002508 1.8 63.8 Curative (C) 2018-01-17 2018-04-20 AML MyeChild 01 B Cytarabine/Daunoxome + GO N N 220030454 NOT MATCHED
220006509 220002508 1.77 76 Disease modification (D) 2016-02-24 2016-02-24 AML 19 TRIAL Y N 220030454 AML19 TRIAL
220006510 220016154 null 54 Curative (C) 2015-03-19 2015-03-19 null N N 220030457 NOT MATCHED
220006511 220016154 1.75 126.7 Neo-adjuvant (N) 2016-04-11 2016-04-13 AML 19 TRIAL 01 N 220030457 AML19 TRIAL
220006512 220016154 1.88 null null 2015-09-05 2016-03-20 Nilotinib N N 220030457 NILOTINIB
220006513 220016154 1.75 81 Curative (C) 2016-12-30 2016-12-30 AML 19 TRIAL Y N 220030457 AML19 TRIAL
220006514 220002509 1.85 71.1 Curative (C) 2015-07-24 2015-07-24 AML 19 TRIAL Y N 220030463 AML19 TRIAL
220006515 220002509 1.68 64 Curative (C) 2017-06-01 2017-06-02 AML 19 TRIAL Y N 220030463 AML19 TRIAL
220006518 220016155 0 null Curative (C) 2013-08-25 2013-08-30 null N N 220030471 NOT MATCHED
220006519 220016155 null 111 Palliative (P) null 2014-12-25 Nilotinib 02 N 220030471 NILOTINIB
220006520 220016155 0 null null 2017-10-22 2017-10-22 Nilotinib N N 220030471 NILOTINIB
220006521 220002511 1.56 0 Palliative (P) 2016-06-09 2016-06-12 null 2 N 220030478 NOT MATCHED
220006522 220011441 null null Adjuvant (A) 2015-07-13 2015-07-13 Nilotinib N N 220030481 NILOTINIB
220006523 220002512 0 46.2 Curative (C) 2013-03-13 2013-03-23 Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE 1 N 220030482 NOT MATCHED
220006524 220002513 0 null Curative (C) 2013-07-28 2013-07-28 Nilotinib 99 N 220030485 NILOTINIB
220006525 220002513 1.75 0 Disease modification (D) 2013-04-12 2013-04-12 Nilotinib 02 N 220030485 NILOTINIB
220006526 220002513 1.9 0 Palliative (P) 2013-10-31 2013-10-31 AML MyeChild 01 IT Cyt N N 220030485 NOT MATCHED
220006527 220018838 null null Curative (C) 2013-02-20 2013-05-27 null Y null 220030493 NOT MATCHED
220006528 220018838 1.74 0 Curative (C) 2018-01-05 2018-01-05 Nilotinib N N 220030493 NILOTINIB
220006529 220018838 1.65 68.6 Curative (C) 2014-07-22 2014-07-22 AML 19 TRIAL Y N 220030493 AML19 TRIAL
220006530 220021734 1.66 87.5 Curative (C) 2013-11-11 2013-11-11 AML 19 TRIAL 01 N 220030497 AML19 TRIAL
220006531 220002514 null null Disease modification (D) 2018-04-09 2018-04-09 Nilotinib N N 220030498 NILOTINIB
220006532 220002515 1.64 68.2 Curative (C) 2014-03-22 2014-03-22 AML 19 TRIAL Y N 220030500 AML19 TRIAL
220006533 220011443 0 null Curative (C) null 2016-03-15 FLAG + Idarubicin N null 220030501 FLAG + IDARUBICIN
220006534 220002516 1.77 null Curative (C) 2013-03-23 2013-03-29 Nilotinib 2 N 220030506 NILOTINIB
220006535 220002516 1.7 69.4 Curative (C) 2017-09-16 2017-09-16 AML 19 TRIAL 1 N 220030506 AML19 TRIAL
220006536 220002516 null 22.6 Curative (C) 2015-04-01 2015-04-02 null 02 null 220030506 NOT MATCHED
220006537 220002517 0 96.2 Disease modification (D) 2014-02-20 2014-02-20 Nilotinib N N 220030509 NILOTINIB
220006538 220002517 0 null Disease modification (D) 2015-07-20 2015-07-26 Nilotinib N N 220030509 NILOTINIB
220006539 220002518 1.72 57.6 Curative (C) null 2016-01-07 AML 19 TRIAL Y N 220030513 AML19 TRIAL
220006540 220002518 1.67 75 null 2015-01-15 2015-01-15 FLAG + Idarubicin 02 N 220030513 FLAG + IDARUBICIN
220006541 220002519 1.94 77.5 null 2015-06-29 2015-06-29 FLAG + Idarubicin N N 220030516 FLAG + IDARUBICIN
220006542 220002519 1.8 63.9 Curative (C) 2016-10-04 2016-10-06 AML 19 TRIAL 1 N 220030516 AML19 TRIAL
220006543 220002520 1.73 77.5 Disease modification (D) 2013-05-01 2013-05-05 FLAG + Idarubicin 02 N 220030520 FLAG + IDARUBICIN
220006544 220002520 null 84.9 Palliative (P) 2016-08-02 2016-08-02 Nilotinib 02 N 220030520 NILOTINIB
220006545 220002521 1.93 76.4 Curative (C) 2014-09-30 2014-09-30 AML 19 TRIAL 1 N 220030523 AML19 TRIAL
220006546 220002522 1.81 21 Curative (C) 2013-02-20 2013-02-20 CML Dasatinib N N 220030524 NOT MATCHED
220006547 220002522 0 null Disease modification (D) 2015-07-15 2015-07-15 Nilotinib 99 N 220030524 NILOTINIB
220006548 220002523 1.52 17 Curative (C) null 2015-03-03 AML Interim Guidelines FLA -Ida N N 220030529 NOT MATCHED
220006549 220011450 null 0 Curative (C) 2014-09-18 2014-09-18 Nilotinib N N 220030530 NILOTINIB
220006550 220002524 1.71 61 Curative (C) 2017-06-04 2017-06-04 AML 19 TRIAL N N 220030531 AML19 TRIAL
220006551 220002524 1.75 75 Curative (C) 2015-09-28 2015-10-17 FLAG + Idarubicin N N 220030531 FLAG + IDARUBICIN
220006552 220002524 1.76 55.9 Curative (C) null 2016-09-29 FLAG + Idarubicin 02 N 220030531 FLAG + IDARUBICIN
220006553 220002524 1.85 95.8 Curative (C) null 2017-10-02 AML 19 TRIAL 01 N 220030531 AML19 TRIAL